Direxion Daily Semiconductor Bear 3X Shares vs Vertex Pharmaceuticals Incorporated — how do they compare? Direxion Daily Semiconductor Bear 3X Shares trades at $41.51, while Vertex Pharmaceuticals Incorporated trades at $529.98 (market cap $134.25B). Which is the better fit depends on your goals.
| SOXS | VRTX | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $1.49K | $529.65 |
52-Week Low | $32.50 | $376.62 |
Market Cap | — | $134.25B |
Enterprise Value | — | $128.37B |
Trailing returns across standard periods
SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →